Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
2,879
Price
$67.73
Total Value
$194.99K
Shares Held After
50,662
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,467
Price
$478.92
Total Value
$702.57K
Shares Held After
36,781
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,100
Price
$478.15
Total Value
$1.00M
Shares Held After
38,248
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,114
Price
$477.10
Total Value
$531.48K
Shares Held After
40,348
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
881
Price
$475.89
Total Value
$419.26K
Shares Held After
41,462
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,059
Price
$475.09
Total Value
$503.12K
Shares Held After
42,343
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
288
Price
$473.23
Total Value
$136.29K
Shares Held After
43,402
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
775
Price
$472.76
Total Value
$366.39K
Shares Held After
43,690
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
616
Price
$471.36
Total Value
$290.36K
Shares Held After
44,465
% of Holdings
1.4%
EXELIXIS, INC. (EXEL)
WYSZOMIERSKI JACK L — Director
Shares
99,574
Price
$44.01
Total Value
$4.38M
Shares Held After
279,942
% of Holdings
26.2%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
423
Price
$73.00
Total Value
$30.88K
Shares Held After
75,489
% of Holdings
0.6%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
180
Price
$73.00
Total Value
$13.14K
Shares Held After
21,174
% of Holdings
0.8%
MapLight Therapeutics, Inc. (MPLT)
Pavlov George — Director
Shares
10,658
Price
$17.48
Total Value
$186.30K
Shares Held After
10,658
% of Holdings
100.0%
PTC THERAPEUTICS, INC. (PTCT)
Gravier Pierre — CHIEF FINANCIAL OFFICER
Shares
2,992
Price
$69.36
Total Value
$207.53K
Shares Held After
87,318
% of Holdings
3.3%
PTC THERAPEUTICS, INC. (PTCT)
Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Shares
2,484
Price
$69.36
Total Value
$172.29K
Shares Held After
89,944
% of Holdings
2.7%
PTC THERAPEUTICS, INC. (PTCT)
Pauwels Eric — CHIEF BUSINESS OFFICER
Shares
3,019
Price
$69.36
Total Value
$209.40K
Shares Held After
77,122
% of Holdings
3.8%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
1,800
Price
$29.58
Total Value
$53.25K
Shares Held After
174,209
% of Holdings
1.0%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
2,200
Price
$28.46
Total Value
$62.61K
Shares Held After
176,009
% of Holdings
1.2%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
7,371
Price
$69.36
Total Value
$511.25K
Shares Held After
387,082
% of Holdings
1.9%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
65
Price
$69.36
Total Value
$4.51K
Shares Held After
6,726
% of Holdings
1.0%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
3,056
Price
$69.36
Total Value
$211.96K
Shares Held After
112,140
% of Holdings
2.7%
Lexeo Therapeutics, Inc. (LXEO)
Otero Jose Manuel — Chief Operating Officer
Shares
3,016
Price
$6.40
Total Value
$19.29K
Shares Held After
125,460
% of Holdings
2.3%
Annexon, Inc. (ANNX)
Overdorf Michael — EVP & CHIEF BUSINESS OFFICER
Shares
6,225
Price
$5.10
Total Value
$31.75K
Shares Held After
124,464
% of Holdings
4.8%
Lexeo Therapeutics, Inc. (LXEO)
Townsend Richard Nolan — Director
Shares
10,173
Price
$6.38
Total Value
$64.92K
Shares Held After
392,483
% of Holdings
2.5%
PTC THERAPEUTICS, INC. (PTCT)
Utter Christine Marie — SVP, CHIEF ACCOUNTING OFFICER
Shares
2,494
Price
$69.36
Total Value
$172.98K
Shares Held After
70,199
% of Holdings
3.4%
Annexon, Inc. (ANNX)
ARTIS DEAN RICHARD — EVP & CHIEF SCIENTIFIC OFFICER
Shares
5,290
Price
$5.10
Total Value
$26.98K
Shares Held After
123,487
% of Holdings
4.1%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Militello John — See Remarks
Shares
1,157
Price
$3.34
Total Value
$3.86K
Shares Held After
91,019
% of Holdings
1.3%
Annexon, Inc. (ANNX)
Lew Jennifer — EVP & CHIEF FINANCIAL OFFICER
Shares
7,851
Price
$5.11
Total Value
$40.12K
Shares Held After
113,765
% of Holdings
6.5%
Annexon, Inc. (ANNX)
Yednock Ted — EVP & CHIEF INNOVATION OFFICER
Shares
7,857
Price
$5.11
Total Value
$40.15K
Shares Held After
97,227
% of Holdings
7.5%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Pinto Shelly — SVP, FINANCE AND CAO
Shares
565
Price
$2.27
Total Value
$1.28K
Shares Held After
87,708
% of Holdings
0.6%
Keros Therapeutics, Inc. (KROS)
Regnante Keith — CHIEF FINANCIAL OFFICER
Shares
4,739
Price
$16.35
Total Value
$77.48K
Shares Held After
39,261
% of Holdings
10.8%
Annexon, Inc. (ANNX)
Dananberg Jamie — CHIEF MEDICAL OFFICER
Shares
5,290
Price
$5.10
Total Value
$26.98K
Shares Held After
73,152
% of Holdings
6.7%
Voyager Therapeutics, Inc. (VYGR)
Swartz Robin — COO & CBO
Shares
3,882
Price
$3.44
Total Value
$13.35K
Shares Held After
206,196
% of Holdings
1.8%
Keros Therapeutics, Inc. (KROS)
Lerner Lorena Raquel — Chief Science Officer
Shares
3,873
Price
$16.35
Total Value
$63.32K
Shares Held After
31,127
% of Holdings
11.1%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
1,376
Price
$3.34
Total Value
$4.59K
Shares Held After
682,000
% of Holdings
0.2%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
5,990
Price
$3.34
Total Value
$19.99K
Shares Held After
1,046,055
% of Holdings
0.6%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,276
Price
$79.97
Total Value
$102.04K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
3,026
Price
$79.16
Total Value
$239.53K
Shares Held After
1,276
% of Holdings
70.3%
Voyager Therapeutics, Inc. (VYGR)
Carter Todd Alfred — Chief Scientific Officer
Shares
3,301
Price
$3.44
Total Value
$11.36K
Shares Held After
149,892
% of Holdings
2.2%
Keros Therapeutics, Inc. (KROS)
Cho Esther — SVP, General Counsel
Shares
4,745
Price
$16.35
Total Value
$77.58K
Shares Held After
39,755
% of Holdings
10.7%
Voyager Therapeutics, Inc. (VYGR)
Sandrock Alfred — Director
Shares
11,732
Price
$3.41
Total Value
$40.01K
Shares Held After
498,257
% of Holdings
2.3%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Taylor Ben R — Chief Financial Officer
Shares
13,426
Price
$3.08
Total Value
$41.35K
Shares Held After
1,195,349
% of Holdings
1.1%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
1,109
Price
$15.00
Total Value
$16.64K
Shares Held After
224,173
% of Holdings
0.5%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
1,163
Price
$15.00
Total Value
$17.45K
Shares Held After
133,087
% of Holdings
0.9%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
1,038
Price
$15.00
Total Value
$15.57K
Shares Held After
429,667
% of Holdings
0.2%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,100
Price
$29.80
Total Value
$62.57K
Shares Held After
20,729
% of Holdings
9.2%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,983
Price
$29.04
Total Value
$86.64K
Shares Held After
22,829
% of Holdings
11.6%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,281
Price
$29.80
Total Value
$67.97K
Shares Held After
556,247
% of Holdings
0.4%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
3,552
Price
$29.05
Total Value
$103.19K
Shares Held After
558,528
% of Holdings
0.6%
EXELIXIS, INC. (EXEL)
Smith Julie — Director
Shares
20,030
Price
$44.30
Total Value
$887.33K
Shares Held After
20,590
% of Holdings
49.3%
Showing 301–350 of 936 transactions (page 7 of 19)